STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
89
13F, latest reported quarter
Conversions, 180 days
7
Codes C/M, not in net · $85.5K priced
What the filings say about BZAI
Insiders, 180 days
-$453.5K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Blaize insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Blaize Holdings, Inc. insiders sold a net $453.5K of stock across 9 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jun 8, 2026.
1 other insider sold within 30 days.
89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cannestra Anthony sold about $67.5K of BZAI on Jul 6, 2026; 1 other insider sold within 30 days and 89 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jun 1, 2026.
The trade is 15.6% of the 259,773 shares held after it.
1 other insider sold within 30 days.
89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Sehmi Harminder sold about $55.6K of BZAI on Jul 1, 2026; 1 other insider sold within 30 days and 89 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 11, 2026.
1 other insider sold within 30 days.
89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cannestra Anthony sold about $84.0K of BZAI on Jun 8, 2026; 1 other insider sold within 30 days and 89 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 1, 2026.
The trade is 13.5% of the 300,382 shares held after it.
1 other insider sold within 30 days.
89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Sehmi Harminder sold about $73.9K of BZAI on Jun 1, 2026; 1 other insider sold within 30 days and 89 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Apr 6, 2026.
2 other insiders sold within 30 days.
89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cannestra Anthony sold about $92.5K of BZAI on May 11, 2026; 2 other insiders sold within 30 days and 89 funds added in the latest 13F quarter.
9 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BZAI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
ANTHONY CANNESTRA
Filed 2026-07-06
$67.7K
HARMINDER SEHMI
Filed 2026-07-01
$56.0K
BZAI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Themes Generative Artificial Intelligence ETF
$1.1M position · as of 2026-06-30
3.1%
Lazard US Systematic Small Cap Equity ETF
$158.1K position · as of 2026-06-30
0.2%
Ultra-Small Company Market Fund
$141.4K position · as of 2026-06-30
0.1%
iShares Micro-Cap ETF
$399.8K position · as of 2026-06-30
0.0%
Small Company Growth Portfolio
$4.9K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$27.1K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $453.5K sold by insiders over 180 days, 89 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$50.4M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM BZAI
FY Dec 2025
$38.6M
FY Dec 2024
$1.6M
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
$12.0M
Mar 2026
$2.7M
Dec 2025
$23.8M
Sep 2025
$11.9M
Jun 2025
$2.0M
Mar 2025
$1.0M
Dec 2024
$1.0K
Sep 2024
$781.0K
At each fiscal year end
Single quarter
Net margin, TTM
-160.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM BZAI
FY Dec 2025
-535.6%
FY Dec 2024
-3,938%
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
-240.4%
Mar 2026
-827.4%
Dec 2025
-13.9%
Sep 2025
-221.3%
Jun 2025
-1,493%
Mar 2025
-14,673%
Dec 2024
n/a
Sep 2024
-3,279%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$83.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM BZAI
FY Dec 2025
-$74.5M
FY Dec 2024
-$54.4M
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
-$29.2M
Mar 2026
-$12.7M
Dec 2025
-$16.5M
Sep 2025
-$24.9M
Jun 2025
-$16.4M
Mar 2025
-$16.6M
Dec 2024
-$17.5M
Sep 2024
-$15.2M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-426.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
-426.6%
Mar 2026
-388.1%
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-121.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BZAI
FY Dec 2025
-229.0%
FY Dec 2024
-81.0%
FY Dec 2023
+0.7%
FY Dec 2022
+0.6%
Jun 2026
-121.5%
Mar 2026
-95.7%
Dec 2025
-229.0%
Sep 2025
-378.9%
Jun 2025
-407.5%
Mar 2025
-259.1%
Dec 2024
-81.0%
Sep 2024
-90.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-265.3%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
-2.0%
FY Dec 2022
-0.5%
Jun 2026
-265.3%
Mar 2026
-168.4%
Dec 2025
n/a
Sep 2025
-311.7%
Jun 2025
-322.0%
Mar 2025
-150.6%
Dec 2024
n/a
Sep 2024
-60.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-297.1%
TTM free cash flow over market value at close 2026-10-27
FCF yield BZAI
FY Dec 2025
-34.4%
FY Dec 2024
-23.9%
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
-42.5%
Mar 2026
-31.6%
Dec 2025
-34.4%
Sep 2025
-21.3%
Jun 2025
-21.7%
Mar 2025
-30.9%
Dec 2024
-23.9%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing BZAI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BZAI ranks highest on growth (99th percentile) and institutional and government (39th), and lowest on profitability (5th), among Semiconductors & Electronics peers.
Profitability
5
Inputs
Return on equity-426.6% · 4 pct, sector of 154
Return on assets-121.5% · 6 pct, sector of 171
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-265.3% · 4 pct, sector of 155
Growth
99
Inputs
Revenue growth, YoY+2386% · 99 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
35
Inputs
Net Form 4 buying (codes P and S), 180d-$454K · 71 pct, sector of 147
Insider buyers, 180d0 · 0 pct, sector of 151
Institutional and government
39
Inputs
Funds adding, latest quarter89 · 39 pct, sector of 184
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
12
Inputs
Short interest, % of float+18.6% · 11 pct, sector of 221
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+26.7% · 13 pct, sector of 152
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BZAI filings, in plain words
Are Blaize insiders buying or selling BZAI?
In the 180 days to 2026-10-28, Blaize insiders were net sellers, a net $453.5K across purchases and sales reported on Form 4, by 2 sellers.
Read the full summary
In the 180 days to 2026-10-28, Blaize insiders were net sellers of BZAI, a net $453.5K across purchases and sales reported on Form 4 by 2 sellers. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.